NABRIVA THERAPEUTICS AG's ticker is NBRVXXXX and the CUSIP is 62957M104. A total of 21 filers reported holding NABRIVA THERAPEUTICS AG in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,151,700 | $22,219,000 | 6.92% |
| Omega Fund Management, LLC | 1,145,890 | $8,079,000 | 6.17% |
| ACUTA CAPITAL PARTNERS, LLC | 583,521 | $4,114,000 | 1.54% |
| EcoR1 Capital, LLC | 548,912 | $3,870,000 | 1.19% |
| Opaleye Management Inc. | 239,500 | $1,688,000 | 0.88% |
| Novo Holdings A/S | 1,116,660 | $7,872,000 | 0.70% |
| Boxer Capital, LLC | 176,710 | $1,246,000 | 0.56% |
| FT Options LLC | 58,055 | $414,000 | 0.33% |
| JACKSON PARK CAPITAL, LLC | 26,000 | $185,000 | 0.24% |
| Rock Springs Capital Management LP | 426,000 | $3,003,000 | 0.19% |